The rapid progress of generative AI, exemplified by Open AI’s ChatGPT and its capacity for lifelike conversations and image/video generation, has sparked both interest and concern in its potential applications in healthcare. While AI has demonstrated impressive capabilities in medicine, such as interpreting medical images and driving progress in infectious diseases and molecular medicine, the full potential of generative AI in the field remains largely speculative. Though initiatives aim to utilize AI for various healthcare tasks, concerns persist around its applicability to diverse datasets, potential errors, privacy breaches, and exacerbation of biases in healthcare access and data representation, all of which contribute to the erosion of patient trust.

The Lancet Oncology recently published an article regarding one of the first randomized controlled trials of AI-supported mammography. However, there are serious risks which must be considered. 1

Read more here.

References

  1. The Lancet, volume 402. August 12, 2023

Disclaimers

  • The material in these reviews is from various public open-access sources, meant for educational and informational purposes only
  • Any personal opinions expressed are those of only the author(s) and are not intended to represent the position of any organization(s)
  • No official support by any organization(s) has been provided or should be inferred